Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study

[1]  F. Wessels,et al.  Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT , 2019, Advances in radiation oncology.

[2]  R. Valkema,et al.  Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[3]  Joe Y. Chang,et al.  Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  E. Steyerberg,et al.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. , 2015, The Lancet. Oncology.

[5]  Jan-Jakob Sonke,et al.  Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Daniel T Chang,et al.  Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. , 2015, International journal of radiation oncology, biology, physics.

[7]  M. V. van Herk,et al.  Clinical evaluation of respiration-induced attenuation uncertainties in pulmonary 3D PET/CT , 2015, EJNMMI Physics.

[8]  J. V. van Sandick,et al.  Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer , 2014, Clinical nuclear medicine.

[9]  M. Moerland,et al.  Quantification of esophageal tumor motion on cine-magnetic resonance imaging. , 2014, International journal of radiation oncology, biology, physics.

[10]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[11]  G. Meijer,et al.  Imaging strategies in the management of oesophageal cancer: what’s the role of MRI? , 2013, European Radiology.

[12]  T. Rice,et al.  Diagnosis and staging of cancer of the esophagus and esophagogastric junction. , 2012, The Surgical clinics of North America.

[13]  J. Ajani,et al.  Failure patterns in patients with esophageal cancer treated with definitive chemoradiation , 2012, Cancer.

[14]  Kristin D. Brockway,et al.  What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. , 2012, International journal of radiation oncology, biology, physics.

[15]  V. Gebski,et al.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.

[16]  J. Pruim,et al.  A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  J. Lee,et al.  Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  E. J. van der Jagt,et al.  Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition. , 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[19]  P. Price,et al.  Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning. , 2010, World journal of gastrointestinal oncology.

[20]  Habib Zaidi,et al.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Jinming Yu,et al.  Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. , 2010, International journal of radiation oncology, biology, physics.

[22]  Andrzej Niemierko,et al.  Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. , 2009, International journal of radiation oncology, biology, physics.

[23]  E. Kouwenhoven,et al.  Measuring the similarity of target volume delineations independent of the number of observers , 2009, Physics in medicine and biology.

[24]  M. Mamede,et al.  Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. , 2008, International journal of radiation oncology, biology, physics.

[25]  K. Brock,et al.  Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[26]  G. Fakhri,et al.  Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation , 2007, Annals of nuclear medicine.

[27]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Joe Y. Chang,et al.  Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. , 2007, International journal of radiation oncology, biology, physics.

[29]  David Binns,et al.  A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  J. Plukker,et al.  Role of positron emission tomography in the (re-)staging of oesophageal cancer , 2006, Scandinavian journal of gastroenterology. Supplement.

[31]  Hanna El Balaa,et al.  Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[32]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  L. Adler,et al.  The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[35]  T. Crosby,et al.  Definitive chemoradiation in patients with inoperable oesophageal carcinoma , 2004, British Journal of Cancer.

[36]  Curtis B Caldwell,et al.  Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. , 2003, International journal of radiation oncology, biology, physics.

[37]  T. Lehnert,et al.  Prospective Comparison of Endoscopy, Endosonography and Computed Tomography for Staging of Tumours of the Oesophagus and Gastric Cardia , 2003, Digestion.

[38]  R. Passariello,et al.  Esophagogram and CT vs endoscopic and surgical specimens in the diagnosis of esophageal carcinoma. , 2002, La Radiologia medica.

[39]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  L. Stitt,et al.  Variability of target volume delineation in cervical esophageal cancer. , 1998, International journal of radiation oncology, biology, physics.

[41]  L. M. Antonia.  FDG-PET/CT in staging and treatment of esophageal cancer , 2014 .

[42]  J. Ajani,et al.  Factors Associated with Local–Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer , 2013, Annals of Surgical Oncology.

[43]  Jasper Nijkamp,et al.  Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  Jinming Yu,et al.  Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.

[45]  M. Mehta,et al.  Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[46]  Marcel van Herk,et al.  Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. , 2005, International journal of radiation oncology, biology, physics.